Loading stock data…
Loading stock data…
US$0.52
Get one email when LYRA crosses your level. Checked every 15 minutes during market hours.
▼ -0.05 (-8.76%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
45.0
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.04
Bearish momentumMACD below its signal line (-0.04).
50-day average
0.65
Price belowShort-term trend reference.
200-day average
2.26
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Lyra Therapeutics Inc. is a biopharmaceutical company focusing on developing therapies for patients with ear, nose, and throat (ENT) diseases. The company's primary purpose is to address the unmet needs in the treatment of chronic rhinosinusitis (CRS) and related conditions by utilizing an innovative polymer-based platform, XTreo, which offers sustained delivery of medications directly to the affected area. This strategic approach aims to enhance treatment efficacy, reduce systemic side effects,…
lyratherapeutics.com0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-07-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-06-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-05-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-29 | 0.74 | 0.92 | ✓ Beat |
| 2026-05-06 | 2.55 | 2.72 | ✓ Beat |
| 2026-02-12 | 1.03 | 1.07 | ✓ Beat |
| 2025-11-12 | -4.07 | -3.4 | ✓ Beat |
| 2025-09-10 | -0.16 | -0.31 | ✗ Miss |
| 2025-08-12 | -4.78 | -5.22 | ✗ Miss |
| 2025-05-06 | -6.83 | -6.5 | ✓ Beat |
| 2025-03-13 | -6.5 | -7.09 | ✗ Miss |
Companies in the same industry, via Finnhub